Dexcom Products

Medicare CGM

The Dexcom G6 Continuous Glucose Monitoring (CGM) System can be prescribed for your type 1 and type 2 Medicare patients who meet qualifying criteria.

Dexcom_G6_CGM for Medicare

You are here

Dexcom CGM for Your Medicare Patients

Seniors with diabetes frequently experience severe hypoglycemia and impaired awareness of hypoglycemia.1,2 Dexcom G6 is now available for Medicare patients,* offering this vulnerable population an additional layer of support.

Medicare Coverage and Prescribing Information

*For the full list of Medicare coverage criteria, visit the Centers for Medicare and Medicaid services website.

Dexcom G6 CGM for Medicare Patients

Zero Fingersticks**

The Dexcom G6 is permitted as a replacement for fingersticks for diabetes treatment decisions, including dosing.**

**Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Easy Sensor Insertion<sup>3</sup>

The auto applicator allows for simple,
one-touch sensor insertion.3

Can Help Reduce A1C<sup>4,5</sup>

CGM use has been shown to reduce A1C in patients with type 1 who are above the age of 60 years.4,5

A Closer Look at the Dexcom G6 Components

  1. Sensor - monitors interstitial glucose levels through a small wire inserted just underneath the skin, sending a signal to the transmitter.
  2. Transmitter - fastened on top of the sensor; sends data wirelessly to a display device.
  3. Display device - shows glucose readings and trend data on the touchscreen receiver or the patient’s compatible smart device.
  4. Auto applicator - simplifies the sensor insertion process with one-button push insertion.1

​To learn more about the Dexcom G6 Components and setup please read the Dexcom G6 Start Here Guide.

Dexcom_G6_CGM

Studies Show that Dexcom CGM Use Can Benefit Seniors

A1C Reduction

Some clinicians may assume that CGM may be too complicated for use in an older population. However, a study of adults ages ≥ 60 years with type 1 or type 2 diabetes demonstrated an average 0.9% reduction in A1C among participants randomized to Dexcom CGM.6

A1C Reduction for Medicare with Dexcom CGM

Reduction of Severe Hypo

Seniors, who frequently exhibit impaired awareness of hypoglycemia, may also be at greater risk for severe hypoglycemic incidents.6 Dexcom CGM users ages 65 and older with type 1 or type 2 diabetes report significantly fewer episodes of severe hypoglycemia than non-CGM users in this same age category.7

Improved Quality of Life

Dexcom CGM users ages 65 years and older with type 1 or type 2 diabetes report significantly greater well-being, less hypoglycemic fear, and less diabetes distress than non-CGM users in this same age category.7

Forms_Medicare Certificate of Medical Necessity

Medicare Coverage and Prescribing Information

Review coverage information and how to prescribe Dexcom G6 to your Medicare patients.

Learn More

Medicare Coding

Medicare Coding

Find the latest coding references and billing instructions for Medicare patients.

Learn More

Medicare Frequently Asked Questions

Medicare Frequently Asked Questions

Learn about Medicare coverage criteria, distribution options, and more.

See FAQs

*For the full list of Medicare coverage criteria, visit the Centers for Medicare and Medicaid services website.
**Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
For a list of compatible devices, please visit dexcom.com/compatibility.
1Weinstock RS, DuBose SN, Bergenstal RM, Chaytor NS, Peterson C, Olson BA, Munshi MN, Perrin AJ, Miller KM, Beck RW, Liljenquist DR, Aleppo G, Buse JB, Kruger D, Bhargava A, Goland RS, Edelen RC, Pratley RE, Peters AL, Rodriguez H, Ahmann AJ, Lock JP, Garg SK, Rickels MR, Hirsch IB; T1D Exchange Severe Hypoglycemia in Older Adults With Type 1 Diabetes Study Groups. Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. Diabetes Care. 2016;39(4):603-610.
2DuBose SN, Weinstock RS, Beck RW, Peters AL, Aleppo G, Bergenstal RM, Rodriguez H, Largay JF, Massaro EM, Hirsch IB. Hypoglycemia in older adults with type 1 diabetes. Diabetes Technol Ther. 2016;18(12):765-771.
3Dexcom G6 CGM System User Guide, 2018.
4Pratley RE. Wireless Innovations for Seniors with Diabetes Mellitus—Primary Results of the WISDM Study. Oral presentation: American Diabetes Association 79th Scientific Sessions; June 7-11, San Francisco, CA
5Welsh JB, Gao P, Derdzinski M, Puhr S, Johnson TK, Walker TC, Graham C. Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems. Diabetes Technol Ther. 2019;21(3):128-132.
6Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C, Group DS. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial. J Diabetes Sci Technol. 2017;11(6):1138-1146.
7Polonsky WH, Peters AL, Hessler D. The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older. J Diabetes Sci Technol. 2016;10(4):892-897.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.